The role of molecular markers in the staging of renal cell carcinoma
- 1 May 2007
- journal article
- review article
- Published by Wiley in BJU International
- Vol. 99 (5b), 1208-1211
- https://doi.org/10.1111/j.1464-410x.2007.06812.x
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- Cancer Statistics, 2006CA: A Cancer Journal for Clinicians, 2006
- Clear Cell Renal Cell Carcinoma: Gene Expression Analyses Identify a Potential Signature for Tumor AggressivenessClinical Cancer Research, 2005
- Carbonic Anhydrase IX Expression Predicts Outcome of Interleukin 2 Therapy for Renal CancerClinical Cancer Research, 2005
- USING TUMOR MARKERS TO PREDICT THE SURVIVAL OF PATIENTS WITH METASTATIC RENAL CELL CARCINOMAJournal of Urology, 2005
- Bevacizumab for Patients with Metastatic Renal CancerClinical Cancer Research, 2004
- Using Protein Expressions to Predict Survival in Clear Cell Renal CarcinomaClinical Cancer Research, 2004
- Use of the University of California Los Angeles Integrated Staging System to Predict Survival in Renal Cell Carcinoma: An International Multicenter StudyJournal of Clinical Oncology, 2004
- Molecular subclassification of kidney tumors and the discovery of new diagnostic markersOncogene, 2003
- Randomized Study of High-Dose and Low-Dose Interleukin-2 in Patients With Metastatic Renal CancerJournal of Clinical Oncology, 2003
- A POSTOPERATIVE PROGNOSTIC NOMOGRAM FOR RENAL CELL CARCINOMAJournal of Urology, 2001